)
Edge29 May 2026
Who You Gonna Call? The Story of Rollins
How Rollins built one of America's most consistent businesses through recurring pest control, trusted local brands, and decades of acquisitions.
IN8bio
IN8bio (INAB) investor relations material
IN8bio Corporate presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Corporate presentation summary2 Jun, 2026
Company overview and team
Clinical-stage biotech focused on gamma-delta (γδ) T cell therapies for cancer and autoimmune diseases.
Team has 35+ years of γδ T cell expertise and deep experience in oncology, immunology, product development, and commercialization.
Platform and technology
Single platform addresses both cancer and autoimmune diseases by resetting or enhancing immune responses.
γδ T cells combine innate and adaptive immune functions, offering potent, durable, and safer responses without genetic engineering.
Higher γδ T cell levels in tumors correlate with improved survival and treatment responses.
Pipeline and clinical programs
Pipeline includes T cell engagers (TCEs) and cellular therapies for leukemia (INB-100), solid tumors (INB-200/400), and autoimmune diseases (INB-619).
INB-619 is a pan-γδ CD19 TCE that expands both Vδ1+ and Vδ2+ γδ T cell subtypes, efficiently depletes B cells, and avoids CD3-driven toxicities.
INB-100 shows dose-dependent expansion of γδ T cells post-transplant, with improved progression-free and overall survival in AML patients.
INB-200/400 for glioblastoma (GBM) demonstrates repeat dosing leads to longer progression-free and overall survival, with strong immune infiltration and tumor remodeling.
How does INB-619 avoid CD3-related toxicities?
What is the mPFS benefit of repeat DRI dosing?
What triggers the potential $20.1M second close?
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from IN8bio
- Repeat dosing of gamma-delta T cell therapies yields strong survival and immune benefits in GBM.INAB
R&D Day 202625 May 2026 - Biopharma innovator targets $200M shelf offering for cell therapy pipeline amid going concern risk.INABRegistration filing18 May 2026
- Net loss narrowed to $5.1M in Q1 2026; strong GBM data and limited cash runway.INABQ1 20268 May 2026
- Gamma delta T cell therapies and novel engagers show strong efficacy and safety, with major milestones ahead.INABBiotech Resurgence: Platforms and Pipelines of Today's Innovators16 Apr 2026
- Virtual meeting to elect directors, ratify auditor, and approve equity plan on May 7, 2026.INABProxy filing26 Mar 2026
- Annual meeting to vote on director elections, auditor ratification, and expanded equity plan.INABProxy filing26 Mar 2026
- Durable remissions and superior safety achieved with γδ T cell therapies in oncology trials.INABInvestor presentation23 Mar 2026
- Clinical progress in glioblastoma and improved financials set up key milestones for 2026.INABQ4 202513 Mar 2026
- Repeat gamma delta T cell dosing in glioblastoma yields superior survival and safety outcomes.INABTD Cowen 46th Annual Health Care Conference2 Mar 2026
Next IN8bio earnings date
Q2 20267 Aug, 2026
IN8bio
Next IN8bio earnings date
Q2 20267 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage